| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ANA.24717 |
| P698 | PubMed publication ID | 27398636 |
| P50 | author | Arnoldo Piccardo | Q42405701 |
| Diego Cecchin | Q55979700 | ||
| Flavio Nobili | Q56550109 | ||
| Cristina Muscio | Q57012507 | ||
| Luigi Antelmi | Q58434914 | ||
| Pietro Tiraboschi | Q87861796 | ||
| P2093 | author name string | Leonardo Sacco | |
| Mauro Tettamanti | |||
| Maria Lucia Calcagni | |||
| Duccio Volterrani | |||
| Selene Capitanio | |||
| Simone Vidale | |||
| Sara Vincenzina Gabanelli | |||
| Ugo Paolo Guerra | |||
| Riccardo Riva | |||
| Stefano Stefanini | |||
| Angelo Corso | |||
| Patrizia Pinto | |||
| Maria Merello | |||
| Anna Micheli | |||
| Ave Maria Biffi | |||
| Paola Vai | |||
| SCILLA Working Group | |||
| P2860 | cites work | Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia | Q24598142 |
| “Mini-mental state” | Q25938989 | ||
| The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis | Q27004240 | ||
| A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale | Q28256570 | ||
| The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
| Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium | Q29614409 | ||
| Low sensitivity in clinical diagnoses of dementia with Lewy bodies | Q33729642 | ||
| Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. | Q33864626 | ||
| Cornell Scale for Depression in Dementia | Q34174895 | ||
| Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop | Q34736093 | ||
| EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. | Q35008440 | ||
| Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies | Q35183572 | ||
| Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand | Q35468295 | ||
| Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. | Q36226812 | ||
| Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease | Q36373719 | ||
| Cardiac sympathetic imaging with mIBG in heart failure | Q37686799 | ||
| Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis | Q37811053 | ||
| Diagnostic accuracy of ¹²³I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies | Q37942729 | ||
| Validation of the Cumulative Illness Rating Scale in a geriatric residential population | Q38481448 | ||
| (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review | Q38531996 | ||
| Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity | Q41165976 | ||
| Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria | Q41264382 | ||
| Diagnostic accuracy of dementia with Lewy bodies | Q41724583 | ||
| Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies | Q42442006 | ||
| Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques? | Q42714191 | ||
| Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology | Q43005897 | ||
| The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic | Q44443421 | ||
| Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. | Q44946964 | ||
| Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. | Q45135867 | ||
| Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD. | Q46168260 | ||
| Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study | Q48240563 | ||
| The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation | Q48279446 | ||
| Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop | Q48342894 | ||
| Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. | Q48384360 | ||
| Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT. | Q48417547 | ||
| DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging | Q48604179 | ||
| A semi-structured interview to assess visual hallucinations in older people. | Q50876392 | ||
| A new clinical scale for the staging of dementia. | Q52220854 | ||
| Research evaluation and prospective diagnosis of dementia with Lewy bodies. | Q53246110 | ||
| Progress in Development of the Index of ADL | Q56004802 | ||
| The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale | Q57814058 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| dementia with Lewy bodies | Q101245788 | ||
| P304 | page(s) | 368-378 | |
| P577 | publication date | 2016-08-02 | |
| P1433 | published in | Annals of Neurology | Q564414 |
| P1476 | title | (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study | |
| P478 | volume | 80 |
| Q100960870 | Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias |
| Q54982491 | Are dementia with Lewy bodies and Parkinson's disease dementia the same disease? |
| Q54443322 | Author's reply "What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?" |
| Q49987358 | Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies. |
| Q61446034 | Dementia with Lewy bodies: an update and outlook |
| Q33869820 | Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium |
| Q52564924 | Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies. |
| Q51766645 | Improving the identification of dementia with Lewy bodies in the context of an Alzheimer's-type dementia. |
| Q39243369 | Lewy Body Disorders |
| Q55339954 | Optimizing Parkinson's disease diagnosis: the role of a dual nuclear imaging algorithm. |
| Q91931101 | REM sleep atonia loss distinguishes synucleinopathy in older adults with cognitive impairment |
| Q38762171 | Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT. |
| Q57635735 | What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective |
| Q48139392 | What is the best imaging technique in discriminating dementia with Lewy bodies from other dementias? |
Search more.